These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24794556)

  • 1. Pacemaker, implantable cardioverter defibrillator, CRT, CRT-D, psychological difficulties and quality of life.
    Calvagna GM; Torrisi G; Giuffrida C; Patanè S
    Int J Cardiol; 2014 Jun; 174(2):378-80. PubMed ID: 24794556
    [No Abstract]   [Full Text] [Related]  

  • 2. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008.
    van Veldhuisen DJ; Maass AH; Priori SG; Stolt P; van Gelder IC; Dickstein K; Swedberg K
    Eur J Heart Fail; 2009 Dec; 11(12):1143-51. PubMed ID: 19884129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life of patients with implantable cardioverter defibrillators compared with that of pacemaker recipients.
    Leosdottir M; Sigurdsson E; Reimarsdottir G; Gottskalksson G; Torfason B; Vigfusdottir M; Eggertsson S; Arnar DO
    Europace; 2006 Mar; 8(3):168-74. PubMed ID: 16627433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
    Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
    Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life and psychological co-morbidities in children and adolescents with cardiac pacemakers and implanted defibrillators: a cohort study in Eastern Germany.
    Paech C; Ebel V; Wagner F; Stadelmann S; Klein AM; Döhnert M; Dähnert I; Gebauer RA
    Cardiol Young; 2020 Apr; 30(4):549-559. PubMed ID: 32279696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cardiac resynchronization therapy and implantable cardioverter defibrillator on quality of life in patients with heart failure: a meta-analysis.
    Chen S; Yin Y; Krucoff MW
    Europace; 2012 Nov; 14(11):1602-7. PubMed ID: 23104857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders.
    Thijssen J; Borleffs CJ; Delgado V; van Rees JB; Mooyaart EA; van Bommel RJ; van Erven L; Boersma E; Bax JJ; Schalij MJ
    J Am Coll Cardiol; 2011 Nov; 58(22):2282-9. PubMed ID: 22093504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy).
    Ruwald MH; Abu-Zeitone A; Jons C; Ruwald AC; McNitt S; Kutyifa V; Zareba W; Moss AJ
    J Am Coll Cardiol; 2013 Oct; 62(15):1343-50. PubMed ID: 23770172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter defibrillator harm?
    Gasparini M; Nisam S
    Europace; 2012 Aug; 14(8):1087-93. PubMed ID: 22389417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life and end-of-life issues for older patients with implanted cardiac rhythm devices.
    Lampert R
    Clin Geriatr Med; 2012 Nov; 28(4):693-702. PubMed ID: 23101578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.
    Masoudi FA; Mi X; Curtis LH; Peterson PN; Curtis JP; Fonarow GC; Hammill SC; Heidenreich PA; Al-Khatib SM; Piccini JP; Qualls LG; Hernandez AF
    Ann Intern Med; 2014 May; 160(9):603-11. PubMed ID: 24798523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality-of-life in pacemaker and implantable cardioverter defibrillator recipients.
    Linde C
    Pacing Clin Electrophysiol; 2000 Jun; 23(6):931-3. PubMed ID: 10879374
    [No Abstract]   [Full Text] [Related]  

  • 15. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.
    Schuchert A; Muto C; Maounis T; Frank R; Boulogne E; Polauck A; Padeletti L;
    Europace; 2013 Jan; 15(1):71-6. PubMed ID: 22927665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between left ventricular ejection fraction post-cardiac resynchronization treatment and subsequent implantable cardioverter defibrillator therapy for sustained ventricular tachyarrhythmias.
    Manfredi JA; Al-Khatib SM; Shaw LK; Thomas L; Fogel RI; Padanilam B; Rardon D; Vatthyam R; Gemma LW; Golden K; Prystowsky EN
    Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):257-64. PubMed ID: 23443618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.
    Morani G; Gasparini M; Zanon F; Casali E; Spotti A; Reggiani A; Bertaglia E; Solimene F; Molon G; Accogli M; Tommasi C; Paoletti Perini A; Ciardiello C; Padeletti L
    Europace; 2013 Sep; 15(9):1273-9. PubMed ID: 23439866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with complete heart block and a pacemaker.
    Porterfield C; DiMarco JP; Mason PK
    Am J Cardiol; 2015 Jan; 115(2):276-8. PubMed ID: 25465940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of cardiac resynchronization therapy combined with implantable cardioverter defibrillator for heart failure: a meta-analysis of 5674 patients.
    Chen S; Ling Z; Kiuchi MG; Yin Y; Krucoff MW
    Europace; 2013 Jul; 15(7):992-1001. PubMed ID: 23419662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices.
    Slotwiner D; Varma N; Akar JG; Annas G; Beardsall M; Fogel RI; Galizio NO; Glotzer TV; Leahy RA; Love CJ; McLean RC; Mittal S; Morichelli L; Patton KK; Raitt MH; Ricci RP; Rickard J; Schoenfeld MH; Serwer GA; Shea J; Varosy P; Verma A; Yu CM
    Heart Rhythm; 2015 Jul; 12(7):e69-100. PubMed ID: 25981148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.